Patents by Inventor Frank Charles Dorsey

Frank Charles Dorsey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240199608
    Abstract: The present disclosure relates to certain AHR agonist compounds, their method of making, and to pharmaceutical compositions comprising the compounds and to methods of using the compounds to treat immune-mediated diseases, such as psoriasis and atopic dermatitis.
    Type: Application
    Filed: November 3, 2023
    Publication date: June 20, 2024
    Inventors: Michael Gregory BELL, Joel Robert CALVIN, Cheryl Ann CARSON, Lacie Marie CHAUVIGNE-HINES, Christian Alexander CLARKE, Frank Charles DORSEY, Douglas Linn GERNERT, Steven James GREEN, William Thomas MCMILLEN, Antonio NAVARRO, John Robert RIZZO
  • Patent number: 11987624
    Abstract: The present invention relates to antibodies that specifically bind human monocarboxylate transporter 1 (MCT1) (“anti-human MCT1 antibodies”), compositions comprising such anti-human MCT1 antibodies, and methods of using such anti-human MCT1 antibodies.
    Type: Grant
    Filed: September 14, 2022
    Date of Patent: May 21, 2024
    Assignee: lmmunometabolism Development Company, LLC
    Inventors: Frank Charles Dorsey, Joseph Benjamin Granger, Kira Vladimirovna Rubtsova, Oliver Schroeder, Wei Wang
  • Publication number: 20230111363
    Abstract: The present invention relates to antibodies that specifically bind human monocarboxylate transporter 1 (MCT1) (“anti-human MCT1 antibodies”), compositions comprising such anti-human MCT1 antibodies, and methods of using such anti-human MCT1 antibodies.
    Type: Application
    Filed: September 14, 2022
    Publication date: April 13, 2023
    Inventors: Frank Charles Dorsey, Joseph Benjamin Granger, Kira Vladimirovna Rubtsova, Oliver Schroeder, Wei Wang